Cargando…

The Intestinal Barrier in Irritable Bowel Syndrome: Subtype-Specific Effects of the Systemic Compartment in an In Vitro Model

BACKGROUND: Irritable bowel syndrome (IBS) is a disorder with multifactorial pathophysiology. Intestinal barrier may be altered, especially in diarrhea-predominant IBS (IBS-D). Several mediators may contribute to increased intestinal permeability in IBS. AIM: We aimed to assess effects of tryptase a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ludidi, Samefko, Jonkers, Daisy, Elamin, Elhaseen, Pieters, Harm-Jan, Schaepkens, Esther, Bours, Paul, Kruimel, Joanna, Conchillo, José, Masclee, Ad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433176/ https://www.ncbi.nlm.nih.gov/pubmed/25978614 http://dx.doi.org/10.1371/journal.pone.0123498

Ejemplares similares

Ethanol Impairs Intestinal Barrier Function in Humans through Mitogen Activated Protein Kinase Signaling: A Combined In Vivo and In Vitro Approach
por: Elamin, Elhaseen, et al.
Publicado: (2014)

Fatty Acid Ethyl Esters Induce Intestinal Epithelial Barrier Dysfunction via a Reactive Oxygen Species-Dependent Mechanism in a Three-Dimensional Cell Culture Model
por: Elamin, Elhaseen, et al.
Publicado: (2013)

Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model
por: Xu, Pan, et al.
Publicado: (2019)

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
por: Keszthelyi, Daniel, et al.
Publicado: (2012)

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021)

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Intestinal barrier function is maintained with aging – a comprehensive study in healthy subjects and irritable bowel syndrome patients
por: Wilms, Ellen, et al.
Publicado: (2020)

Effects of Ethanol and Acetaldehyde on Tight Junction Integrity: In Vitro Study in a Three Dimensional Intestinal Epithelial Cell Culture Model
por: Elamin, Elhaseen, et al.
Publicado: (2012)

Using a Patient Hotel: Perceptions of the Quality of Care by Patients Undergoing Analysis for Gastrointestinal Motility Disorders in the Netherlands
por: Masclee, Gwen MC, et al.
Publicado: (2022)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Antroduodenal motility recording identifies characteristic patterns in gastroparesis related to underlying etiology
por: Hereijgers, Maartje J. M., et al.
Publicado: (2022)

Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease
por: Xu, Pan, et al.
Publicado: (2021)

A novel biomarker panel for irritable bowel syndrome and the application in the general population
por: Mujagic, Zlatan, et al.
Publicado: (2016)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study
por: Masclee, Gwen M. C., et al.
Publicado: (2021)

Patient-Specific Stress–Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study
por: Vork, Lisa, et al.
Publicado: (2020)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Therapeutic strategies in gastroparesis: Results of stepwise approach with diet and prokinetics, Gastric Rest, and PEG‐J: A retrospective analysis
por: Strijbos, Denise, et al.
Publicado: (2019)

Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease
por: Rinsma, Nicolaas F., et al.
Publicado: (2017)

The Experience Sampling Method—Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder
por: Vork, Lisa, et al.
Publicado: (2018)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Evaluation of Psychological Aspects Among Subtypes of Irritable Bowel Syndrome
por: Farzaneh, Neda, et al.
Publicado: (2012)

Irritable bowel syndrome subtype screening characteristics: constipation subtype patient profiles explored
por: Anastasi, Joyce K., et al.
Publicado: (2012)

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
por: De Munck, Toon J. I., et al.
Publicado: (2020)

The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly
por: Wilms, Ellen, et al.
Publicado: (2019)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2016)

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome
por: Su, Qi, et al.
Publicado: (2022)

Measurement of Esophagogastric Junction Distensibility May Assist in Selecting Patients for Endoluminal Gastroesophageal Reflux Disease Surgery: Author’s Reply
por: Smeets, Fabiënne G M, et al.
Publicado: (2015)

Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes
por: Jacobs, Jonathan P., et al.
Publicado: (2023)

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome
por: Omarova, Sholpan, et al.
Publicado: (2023)

The effect of olive leaf extract on cardiovascular health markers: a randomized placebo-controlled clinical trial
por: Stevens, Yala, et al.
Publicado: (2020)

Electrical Stimulation Therapy for Gastroesophageal Reflux Disease
por: Rinsma, Nicolaas F, et al.
Publicado: (2014)

Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults
por: Keshteli, Ammar Hassanzadeh, et al.
Publicado: (2015)

Diet and gut microbial associations in irritable bowel syndrome according to disease subtype
por: Wang, Yiqing, et al.
Publicado: (2023)

Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI
por: Lam, Ching, et al.
Publicado: (2017)

Intraduodenal Administration of Intact Pea Protein Effectively Reduces Food Intake in Both Lean and Obese Male Subjects
por: Geraedts, Maartje C. P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2sac4ku840eugbl1sngfpv89bg